The global automated sample storage systems market size surpassed USD 1.73 billion in 2025 and is predicted to reach around USD 5.47 billion by 2035, registering a CAGR of 12.2% from 2026 to 2035. The rising number of drug tests and core developments is strengthening the biobanks space and accelerating more profit for the market. The advanced traceability advantage is a value-added point for the market.

Automated Sample Storage Systems Market Statical Scope

The automated sample storage systems are software-inspired robotic benefits for healthcare which takes full responsibility for the biological samples. This system operates at a suitable temperature, and a balanced ecosystem brings value and quality to the market. The storage of drug compound libraries and the traffic of patient samples at the biobanks bring precision value to the clinical and research space.

The businesses of this market stand strongly on the integrated advancements and tech-driven solutions that support the operation of the market. Even the molecular biology studies are sharpening with the use of these retrieval samples. Personalized medicine and genomics research are the major sources of revenue for the market.

Automated Sample Storage Systems Market Share, By Region, 2025 (%)

• North America – The North America regional segment dominated the market by 37% of profit with the tech AI unification initiation in sample tracking and identification. This spurs more value to the regional market, while the 2D barcode idea for tracking makes it easier for the sample delivery system.
• Europe – Europe covers 26% of the share with the acceptance of robotics in the main life sciences journey, which further promotes sample traceability. The cloud-related platforms and AI are elevating the modern analytics use in the regional market.
• Asia-Pacific – Asia Pacific leads by 24% of share with the boon of AI-inspired cold storage, which helps the region to retain its excellence in personalized medicine. The sub-regions ' efforts to tap into the market potential are encouraging valuable growth in the regional market.
• LAMEA – LAMEA covers 13% of the share with the supportive healthcare infrastructure that helps the regional market to perform in the advanced ecosystem. The improvisation in data management and lab workflow is an appreciation for the market strength.

Automated Sample Storage Systems Market Share, By Product, 2025 (%)

• Automated Compound Storage Systems – The automated compound storage systems segment dominated the market by 49% of share due to the smooth unification advantage of automation and LIMS. The pneumatic systems add more speed and quick revenue to the segmental market.
• Automated Liquid Handling Systems – The segment covers 33% of the share due to the rising drug discovery numbers. The use of samples and compounds increases with the perk of integration that harnesses more scope for the segmental market for earning.

Automated Sample Storage Systems Market Share, By Sample, 2025 (%)

• Compound Samples – The compound samples segment dominated the market by 64% of share, with more needs from the biotech and pharmaceutical ends. The enhancement to sample integrity confirms accurate growth in the segmental market.
• Biological Samples – The biological samples held 24% of profit, with more assignments to the biobanks and R&D sector. The automated systems and precision medicine are popular sources of profit for the segmental market.

Automated Sample Storage Systems Market Share, By End-user, 2025 (%)

• Pharmaceutical and Biotech Companies – The pharmaceutical and biotech companies segment dominated the market by 42% of share, as efficiency is a major ingredient for the segment to achieve excellence in the drug theory and mechanism. The market potential and commendable research are a boon for the segmental market growth.
• Academic and Research Institutions – The segment held 26% of the share with the required awareness needed to qualify the drug potential with the effective approaches and sample precision involvement. Biobanking is a successful reach for the segmental market growth.
• Biobanks – Biobanks acquires 18% of the shares due to its high-priority responsibility status in the market. The traceability and efficiency potency are a plus point for the segmental market to cooperate with the major integrations and advancements in the relevant medical settings.

Top Companies in the Automated Sample Storage Systems Market

• Thermo Fisher Scientific, Inc.
• Beckman Coulter, Inc. (Danaher)
• Hamilton Company
• Azenta US, Inc.
• MEGAROBO
• SPT Labtech Ltd
• LiCONiC AG
• MICRONIC
• ASKION GmbH
• Haier Biomedical

Segments Covered in the Report

By Product

• Automated Compound Storage System
• Automated Liquid Handling Systems
• Others

By Sample

• Biological Samples
• Compound Samples
• Others

By End-user

• Pharmaceutical and Biotech Companies
• Academic and Research Institutions
• Biobanks
• Others

By Regional

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait